Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
Cancer Immunol Immunother. 2020 Jul;69(7):1315-1326. doi: 10.1007/s00262-020-02549-0. Epub 2020 Mar 20.
Cancer Immunol Immunother. 2020.
PMID: 32198536
Free PMC article.
Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors.
Baram T, Erlichman N, Dadiani M, Balint-Lahat N, Pavlovski A, Meshel T, Morzaev-Sulzbach D, Gal-Yam EN, Barshack I, Ben-Baruch A.
Baram T, et al. Among authors: pavlovski a.
Cells. 2021 Jun 8;10(6):1429. doi: 10.3390/cells10061429.
Cells. 2021.
PMID: 34201054
Free PMC article.
Item in Clipboard
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer.
Dadiani M, Bossel Ben-Moshe N, Paluch-Shimon S, Perry G, Balint N, Marin I, Pavlovski A, Morzaev D, Kahana-Edwin S, Yosepovich A, Gal-Yam EN, Berger R, Barshack I, Domany E, Kaufman B.
Dadiani M, et al. Among authors: pavlovski a.
Clin Cancer Res. 2016 Jul 15;22(14):3651-62. doi: 10.1158/1078-0432.CCR-15-2313. Epub 2016 Mar 8.
Clin Cancer Res. 2016.
PMID: 26957561
Item in Clipboard
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, Sella T, Gadot M, Cesarkas K, Farage-Barhom S, Saar EG, Eyal E, Kol N, Pavlovski A, Balint-Lahat N, Dick-Necula D, Barshack I, Kaufman B, Gal-Yam EN.
Zundelevich A, et al. Among authors: pavlovski a.
Breast Cancer Res. 2020 Feb 3;22(1):16. doi: 10.1186/s13058-020-1246-5.
Breast Cancer Res. 2020.
PMID: 32014063
Free PMC article.
Item in Clipboard
Divergence of mutational signatures in association with breast cancer subtype.
Perry G, Dadiani M, Kahana-Edwin S, Pavlovski A, Markus B, Hornung G, Balint-Lahat N, Yosepovich A, Hout-Siloni G, Jacob-Hirsch J, Sklair-Levy M, Friedman E, Barshack I, Kaufman B, Gal-Yam EN, Paluch-Shimon S.
Perry G, et al. Among authors: pavlovski a.
Mol Carcinog. 2022 Nov;61(11):1056-1070. doi: 10.1002/mc.23461. Epub 2022 Sep 16.
Mol Carcinog. 2022.
PMID: 36111610
Item in Clipboard
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, Sella T, Gadot M, Cesarkas K, Farage-Barhom S, Saar EG, Eyal E, Kol N, Pavlovski A, Balint-Lahat N, Dick-Necula D, Barshack I, Kaufman B, Gal-Yam EN.
Zundelevich A, et al. Among authors: pavlovski a.
Breast Cancer Res. 2020 Mar 12;22(1):28. doi: 10.1186/s13058-020-01265-y.
Breast Cancer Res. 2020.
PMID: 32164744
Free PMC article.
Item in Clipboard
Cite
Cite